Chemotherapy with hybrid liposomes for human breast tumors along with apoptosis in vivo

International Journal of Pharmaceutics

Volumn 372, Issue 1-2, 2009, Pages 162-168

  Shimoda, Shinya ^a   Ichihara, Hideaki ^a   Matsumoto, Yoko ^a   Ueoka, Ryuichi ^a  

^a SOJO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Breast tumor; Chemotherapy; Hybrid liposome

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; DIMYRISTOYLPHOSPHATIDYLCHOLINE; ETHER DERIVATIVE; HYBRID LIPOSOME; LIPOSOME; POLYOXYETHYLENEDODECYL ETHER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST TUMOR; CANCER CHEMOTHERAPY; CANCER INHIBITION; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG METABOLISM; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; IN VIVO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; LIPOSOMES; MICE; MICE, INBRED BALB C; MICE, NUDE; MITOCHONDRIA;

EID: 64149086422     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.01.011     Document Type: Article

References (35)

1. Aiso S., Arito H., Nishizawa T., Nagano K., Yamamoto S., and Matsushima T. Thirteen-week inhalation toxicity of p-dichlorobenzene in mice and rats. J. Occup. Health 47 (2005) 249-260
2. Banciu M., Metselaar J.M., Schiffelers R.M., and Storm G. Antitumor activity of liposomal prednisolone phosphate depends on the presence of functional tumor-associated macrophages in tumor tissue. Neoplasia 10 (2008) 108-117
3. Bangham A.D., Sandish M.M., and Watkins J.C. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 13 (1965) 238-252
4. Baselga J., Tripathy D., Mendelsohn J., Baughman S., Benz C.C., Dantis L., Sklarin N.T., Seidman A.D., Hudis C.A., Moore J., Rosen P.P., Twaddell T., Henderson I.C., and Norton L. Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer. J. Clin. Oncol. 14 (1996) 737-744
5. Casciola-Rosen L., Nicholson D.W., Chong T., Rowan K.R., Thornberry N.A., Miller D.K., and Rosen A. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J. Ext. Med. 183 (1996) 1957-1964
6. Cobleigh M.A., Vogel C.L., Tripathy D., Robert N.J., Scholl S., Fehrenbacher L., Wolter J.M., Paton V., Shak S., Lieberman G., and Slamon D.J. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J. Clin. Oncol. 17 (1999) 2639-2648
7. Gabizon A., Catane R., Uziely B., Kaufman B., Safra T., Cohen R., Martin F., Huang A., and Barenholz Y. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res. 54 (1994) 987-992
8. Graybill J.R., Graven P.C., Taylor R.L., Williams D.M., and Magee W.E. Treatment of murine cryptococcosis with liposome-associated amphotericin B. J. Infect. Dis. 145 (1982) 748-752
9. Ichihara H., Nagami H., Yamamoto K., Matsumoto Y., and Ueoka R. Chemotherapy with hybrid liposomes without any drug in vivo. Yakugaku Zasshi. 123 (2003) 25-34
10. Ichihara H., Nagami H., Kiyokawa T., Matsumoto Y., and Ueoka R. Chemotherapy using hybrid liposomes along with induction of apoptosis. Anticancer Res. 28 (2008) 1187-1196
11. Inaba M., Sato S., Yamori T., Tashiro T., Ohnishi Y., Maruo K., Ueyama Y., and Tsuruo T. Anticancer activities of orally administered menogaril against human stomach and breast cancers implanted in mude mice. Anticancer Res. 12 (1992) 1953-1956
12. Kasai T., Nishizawa T., Arito H., Nagano K., Yamamoto S., Matsushima T., and Kawamoto T. Acute and subchronic inhalation toxicity of chloroform in rats and mice. J. Occup. Health 44 (2002) 193-202
13. Kitamura I., Kochi M., Matsumoto Y., Ueoka R., Kuratsu J., and Ushio Y. Intrathecal chemotherapy with 13-bis(2-chloroethyl)-1-nitrosourea encapsulated into hybrid liposomes for meningeal gliomatosis: an experimental study. Cancer Res. 56 (1996) 3986-3992
14. Komizu Y., Matsumoto Y., and Ueoka R. Membrane targeted chemotherapy with hybrid liposomes for colon tumor cells leading to apoptosis. Bioorg. Med. Chem. Lett. 16 (2006) 6131-6134
15. Komizu Y., Tomonaga Y., Goto K., and Ueoka R. Remarkable immunostimulation effects of hybrid liposomes on human peripheral blood mononuclear cells in vitro. Bioorg. Med. Chem. Lett. 17 (2007) 613-616
16. Kurata M., Sasayama Y., Yamasaki N., Kitazawa I., Hamada Y., and Horii I. Mechanism for shortening PT and APTT in dogs and rats. Effect of fibrinogen on PT and APTT. J. Toxicol. Sci. 28 (2003) 439-443
17. Lee J.S., Park J.I., Kim S.H., Lee H.Y., Hwang Z.Z., Park C.B., Sohn T.U., Shin S., Kang J.K., and Kim Y.B. Oral single- and repeated-dose toxicity studies on Geranti Bio-Ge Yeast, organic germanium fortified yeasts, in dogs. J. Toxicol. Sci. 29 (2004) 555-569
18. In: Lopez-Berestein G., and Finder I. (Eds). Liposomes in the Therapy of Infectious Disease and Cancer (1989), Alan. R. Liss. Inc., New York
19. Matsumoto Y., Kato T., Iseki S., Suzuki H., Nakano K., Iwahara M., and Ueoka R. Remarkably enhanced inhibitory effects of hybrid liposomes on the growth of specific tumor cells. Bioorg. Med. Chem. Lett. 9 (1999) 1937-1940
20. Matsumoto Y., Iwamoto Y., Matsushita T., and Ueoka R. Novel mechanism of hybrid liposomes-induced apoptosis in human tumor cells. Int. J. Cancer 115 (2005) 377-382
21. Nagami H., Matsumoto Y., and Ueoka R. Induction of apoptosis by hybrid liposomes for human breast tumor cells along with activation of caspases. Biol. Pharm. Bull. 29 (2006) 380-381
22. Papahadjopoulos D., and Vail W.T. Incorporation of macromolecules within large unilamellar vesicles. Ann. N. Y. Acad. Sci. 308 (1978) 259-267
23. Postma T.J., Vermorken J.B., Liefting A.J., Pinedo H.M., and Heimans J.J. Paclitaxel-induced neuropathy. Ann. Oncol. 7 (1995) 489-492
24. Reimold E.W. Studies of the toxicity of an intravenous fat emulsion. Hematologic changes and survival after administration of a soybean oil (FE-S15) in beagles. J. Parenter. Enteral. Nutr. 3 (1979) 328-334
25. Senoh H., Aiso S., Arito H., Nishizawa T., Nagano K., Yamamoto S., and Matsushima T. Carcinogenicity and chronic toxicity after inhalation exposure of rats and mice to N,N-dimethylformamide. J. Occup. Health 46 (2004) 429-439
26. Slamon D.J., Clark G.M., Wong S.G., Levin W.J., Ullrich A., and McGuire W.L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235 (1987) 177-182
27. Slamon D.J., Godolphin W., Jones L.A., Holt J.A., Wong S.G., Keith D.E., Levin W.J., Stuart S.G., Udove J., Ullrich A., and Press M.F. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244 (1989) 707-712
28. Slamon D.J., Leyland-Jones B., Shak S., fuchs H., Paton V., Bajamonde A., Fleming T., Eiermann W., Wolter J., Pegram M., Baselga J., and Norton L. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N. Engl. J. Med. 344 (2001) 783-792
29. Tsuruo T., Inaba M., Tashiro T., Yamori T., Ohnishi Y., Ashizawa T., Sakai T., Kobayashi S., and Gomi K. Evaluation of antitumor activity of navelbine (vinorelbine ditartrate) against human breast carcinoma xenografts based on its pharmacokinetics in nude mice. Anti-Cancer Drugs 5 (1994) 634-640
30. Ueoka R., Moss R.A., Swarup S., Matsumoto Y., Strauss G., and Murakami Y. Extraordinary micellar enantioselectivity coupled to altered aggregate structure. J. Am. Chem. Soc. 107 (1985) 2185-2186
31. Ueoka R., Matsumoto Y., Yoshino T., Watanabe N., Omura K., and Murakami Y. Remarkable steric control for the enantioselective cleavage of amino acid esters. Chem. Lett. 15 (1986) 1743-1746
32. Ueoka R., Matsumoto Y., Moss R.A., Swarup S., Sugii A., Harada K., Kikuchi J., and Murakami Y. Membrane matrix for hydrolysis of amino acid esters with marked enantioselectivity. J. Am. Chem. Soc. 110 (1988) 1588-1595
33. Ueoka R., Matsumoto Y., Kanno A., Tsuzaki K., and Ichihara H. Marked therapeutic effect of dimyristoylphosphatidylcholine liposomes on carcinoma mice model in vivo. Biol. Pharm. Bull. 23 (2000) 1262-1263
34. Ueoka R., Matsumoto Y., Ichihara H., and Kiyokawa T. Chemotherapy with hybrid liposomes composed of dimyristoylphosphatidylcholine and polyoxyethylenealkyl ether without drugs. Am. Chem. Soc. Sympos. Ser. 830 (2002) 177-189
35. Zou H., Henzel W.J., Liu X., Lutschg A., and Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90 (1997) 405-413